SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Stephenson who wrote (221)1/10/1998 11:39:00 PM
From: John McCarthy  Respond to of 1321
 
Joe -

First off, thanks alot for your response.

I was confused about when/if/and what they'd have to do
if they intended to revisit the FDA over late stage.

Joe - if you go back a few posts and click on the URL thingie,
(Canada Financial Times) one of the I hate QLTIF analysts
states plainly that early stage cancer is a small market.

It is/was for this reason that I want to find a source for
these numbers.

Regards,

John McCarthy


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News